All translations
Jump to navigation
Jump to search
Enter a message name below to show all available translations.
Found one translation.
| Name | Current message text |
|---|---|
| h English (en) | {| |- | [[File:Iacobuzio-Donahue, Christine article.jpg|200px|left]] || :Christine A. Iacobuzio-Donahue, M.D., Ph.D.Exit Disclaimer :Title: Attending and Member :Institution: Memorial Sloan Kettering Cancer Center :Research: Pancreatic ductal adenocarcinoma (PDAC) is the most common neoplasm of the pancreas and soon the second most common cancer in the U.S. Iacobuzio-Donahue will research features of intratumoral heterogeneity at the genetic level, what cellular factors influence the evolution of PDA, and if therapies influence PDA evolution. Using whole exome/whole genome sequencing of pancreatic cancer tissues, single cell technologies for copy number alterations and RNA expression, long-term evolution experiments, mouse models and computational models, this research will help with identification of optimal agents and timing of administration based on the evolutionary context of the patients' PDA. |} |
